Jorge Duconge to Animals
This is a "connection" page, showing publications Jorge Duconge has written about Animals.
Connection Strength
0.165
-
Ducong? J, Merino N, Alvarez D, Beausoleil I, Fern?ndez-S?nchez E, Rodr?guez L, Burt AD. Kinetics of monoclonal anti-epidermal growth factor receptor antibody (IOR EGF/r3)-induced apoptosis in human carcinoma bearing nude mice. P R Health Sci J. 2008 Mar; 27(1):35-41.
Score: 0.025
-
Ducong? J, Rodr?guez-Vera L, Valenzuela C, Alvarez D, Ram?rez O, de la Luz-Hern?ndez KR, Rabeza-Leg?n EY, Casac? A, Fern?ndez-S?nchez E. Pharmacokinetic comparison of two recombinant human granulocyte colony-stimulating factor after subcutaneous administration in rabbits. Eur J Pharm Biopharm. 2005 Oct; 61(3):142-8.
Score: 0.021
-
Ducong? J, Fern?ndez-S?nchez E, Alvarez D. Interspecies scaling of the monoclonal anti-EGF receptor ior EGF/r3 antibody disposition using allometric paradigm: is it really suitable? Biopharm Drug Dispos. 2004 May; 25(4):177-86.
Score: 0.019
-
Duconge J, Castillo R, Crombet T, Alvarez D, Matheu J, Vecino G, Alonso K, Beausoleil I, Valenzuela C, Becquer MA, Fern?ndez-S?nchez E. Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody. Eur J Pharm Sci. 2004 Feb; 21(2-3):261-70.
Score: 0.019
-
Duconge J, Fern?ndez-S?nchez E, Mac?as A, Castillo R, Garcia I, Beausoleil I, Amador JF, Matheu J. Monoclonal anti-EGFreceptor antibody (ior-R3) pharmacokinetic study in tumor bearing nude mice: role of the receptor-mediated endocytosis on drug clearance. Eur J Drug Metab Pharmacokinet. 2002 Apr-Jun; 27(2):101-5.
Score: 0.017
-
Cruz-Collazo A, Ruiz-Calderon JF, Picon H, Borrero-Garcia LD, Lopez I, Castillo-Pichardo L, Del Mar Maldonado M, Duconge J, Medina JI, Bayro MJ, Hern?ndez-O'Farrill E, Vlaar CP, Dharmawardhane S. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer. Mol Cancer Ther. 2021 12; 20(12):2420-2432.
Score: 0.016
-
Humphries-Bickley T, Castillo-Pichardo L, Corujo-Carro F, Duconge J, Hernandez-O'Farrill E, Vlaar C, Rodriguez-Orengo JF, Cubano L, Dharmawardhane S. Pharmacokinetics of Rac inhibitor EHop-016 in mice by ultra-performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Feb 15; 981-982:19-26.
Score: 0.010
-
Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N. The bio-energetic theory of carcinogenesis. Med Hypotheses. 2012 Oct; 79(4):433-9.
Score: 0.009
-
Garc?a-Santana MA, Duconge J, Sarmiento ME, Lanio-Ru?z ME, Becquer MA, Izquierdo L, Acosta-Dom?nguez A. Biodistribution of liposome-entrapped human gamma-globulin. Biopharm Drug Dispos. 2006 Sep; 27(6):275-83.
Score: 0.006
-
Prats PA, Duconge J, Valenzuela C, Berlanga J, Edrosa CR, Fern?ndez-S?nchez E. Disposition and receptor-site binding of (125)I-EGF after topical administration to skin wounds. Biopharm Drug Dispos. 2002 Mar; 23(2):67-76.
Score: 0.004
-
Fernandez-S?nchez E, Ducong? J, Castillo R, Garcia I, Beausoleil I, Mac?as A. Monoclonal anti-epidermal growth factor receptor (ior EGF/r3) antibody pharmacokinetic studies on nude mice I: a radio-receptor analysis applied to drug serum quantification. J Pharm Pharmacol. 2002 Jan; 54(1):59-64.
Score: 0.004
-
Morales AA, Ducong? J, Alvarez-Ruiz D, Becquer-Viart ML, N??ez-Gandolff G, Fern?ndez E, Caballero-Torres I, Iznaga-Escobar N. Humanized versus murine anti-human epidermal growth factor receptor monoclonal antibodies for immunoscintigraphic studies. Nucl Med Biol. 2000 Feb; 27(2):199-206.
Score: 0.004
-
Morales AA, N??ez-Gandolff G, P?rez NP, V?liz BC, Caballero-Torres I, Ducong? J, Fern?ndez E, Crespo FZ, Veloso A, Iznaga-Escobar N. Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability. Nucl Med Biol. 1999 Aug; 26(6):717-23.
Score: 0.004
-
Morales-Morales A, Ducong? J, Caballero-Torres I, N??ez-Gandolff G, Fern?ndez E, Iznaga-Escobar N. Biodistribution of 99mTc-labeled anti-human epidermal growth factor receptor (EGF-R) humanized monoclonal antibody h-R3 in a xenograft model of human lung adenocarcinoma. Nucl Med Biol. 1999 Apr; 26(3):275-9.
Score: 0.003
-
Iznaga Escobar N, Morales AM, Ducong? J, Torres IC, Fern?ndez E, G?mez JA. Pharmacokinetics, biodistribution and dosimetry of 99mTc-labeled anti-human epidermal growth factor receptor humanized monoclonal antibody R3 in rats. Nucl Med Biol. 1998 Jan; 25(1):17-23.
Score: 0.003